The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.
| Level | Code | Title | |
|---|---|---|---|
| 1 | C | Cardiovascular system | |
| 2 | C07 | Beta blocking agents | |
| 3 | C07B | Beta blocking agents and thiazides | |
| 4 | C07BB | Beta blocking agents, non-selective, and thiazides |
| Code | Title | |
|---|---|---|
| C07BB02 | Metoprolol and thiazides | |
| C07BB03 | Atenolol and thiazides | |
| C07BB04 | Acebutolol and thiazides | |
| C07BB06 | Bevantolol and thiazides | |
| C07BB07 | Bisoprolol and thiazides | |
| C07BB12 | ||
| C07BB52 | Metoprolol and thiazides, combinations |
| Active Ingredient | Description | |
|---|---|---|
| Bisoprolol and Hydrochlorothiazide |
Bisoprolol fumarate and hydrochlorothiazide have been used individually and in combination for the treatment of hypertension. They combine a synthetic beta1-selective (cardioselective) adrenoceptor blocking agent (bisoprolol fumarate) and a benzothiadiazine diuretic (hydrochlorothiazide). The antihypertensive effects of these agents are additive; hydrochlorothiazide significantly increases the antihypertensive effect of bisoprolol fumarate. |
| Title | Information Source | Document Type | |
|---|---|---|---|
| ZIAC Film-coated tablet | FDA, National Drug Code (US) | MPI, US: SPL/Old |
